Navigation Links
Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

nts who discontinued study therapy in ETV-027, and subsequently restarted treatment in rollover study ETV-901, with a greater than 60 day gap between end of treatment in study ETV-027 and start of treatment in study ETV-901.

    -- ETV-027 compared 0.5 mg of BARACLUDE vs. 100 mg of lamivudine in
nucleoside-naive chronic HBeAg-negative chronic hepatitis B patients.
-- Rollover study ETV-901 was established as an open-label, follow-up
protocol for patients in phase II and III studies of BARACLUDE.
-- Due to ongoing blinding of study ETV-027, most patients retreated in
ETV-901 initially received a combination of 1 mg of BARACLUDE plus 100
mg of lamivudine, and were subsequently switched to 1 mg of BARACLUDE
monotherapy.

The analysis cohort was defined regardless of treatment response at the end of dosing in study ETV-027, and independent of virologic or ALT measurements at the start of dosing in study ETV-901. During off-treatment follow-up, the majority of patients had recurrent levels of hepatitis B virus in the blood (viremia) and increases in ALT.

    Data Results
At the end of dosing for study ETV-027:
-- 94 percent (n=93/99) of the re-treatment cohort had undetectable viral
load
-- 78 percent (n=77/99) had ALT normalization
At entry into ETV-901:
-- Four percent (n=4/99) of patients had undetectable viral load
-- Eight percent (n=8/97) of patients had ALT normalization
Following re-treatment in study ETV-901:
-- 93 percent (n=82/88) of patients had undetectable viral load (HBV DNA
<300 copies/mL) by week 48 of re-treatment with BARACLUDE
-- 83 percent (n=79/95) of patients had ALT normalization (ALT less than
or equal to 1 times the upper limit of normal) by week 48 of re-
treatment BARACLUDE
Adverse events in study ETV-027/901 re-treatment cohort:
-- 67 percent (n=66/99) of patients experienced an adverse event. The most
common adverse events occurring in greater than ten percent of patients
were abdominal pain, fa
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
2. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
3. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
7. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
8. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
9. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
10. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
11. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
Post Your Comments:
(Date:3/4/2015)... -- Hill-Rom Holdings, Inc. (NYSE: HRC ) announced ... elected to its Board of Directors.  She most recently ... well as President of Covidien,s Vascular Therapies Division from ... to 2012. Ms. Enxing Seng joined Covidien ... where she was a founding member and executive officer ...
(Date:3/4/2015)... , March 4, 2015  Vanda Pharmaceuticals Inc. ... top-line results of the Phase II proof of ... of tradipitant as a monotherapy in the treatment ... Despite a highly significant and clinically meaningful improvement ... p<0.0001) as measured on a 100mm unit Visual ...
(Date:3/4/2015)... March 4, 2015  The strongest driver of ... the increasing elderly population, according to Kalorama Information. ... from the healthcare market research publisher, Global ... other risk factors such as obesity is contributing ... for innovative product designs and the trend toward ...
Breaking Medicine Technology:Hill-Rom Elects Stacy Enxing Seng to its Board of Directors 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7Kalorama: Growing Elderly Population Drives Orthopedic Device Market 2Kalorama: Growing Elderly Population Drives Orthopedic Device Market 3
... 2011 VIVUS, Inc. (NASDAQ: VVUS ) today ... the European Congress on Obesity (ECO) in Istanbul, Turkey.  ECO ... the Study of Obesity (EASO). ECO is regularly attended by ... considered to be the most important annual scientific event on ...
... and Anne Wojcicki announced a $50-million challenge spurring existing and ... to The Michael J. Fox Foundation for Parkinson,s Research (MJFF). ... new or increased gifts to The Michael J. Fox Foundation ... The Brin Wojcicki Challenge will bolster MJFF,s ongoing efforts to ...
Cached Medicine Technology:Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 2Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 3Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 4Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity 5Brin Wojcicki Foundation Announces $50-Million Challenge Grant to Michael J. Fox Foundation to Spur Progress Toward Parkinson's Cure 2
(Date:3/4/2015)... Imagine No Malaria’s 2014 World Malaria Day ... Award , an honor given to nonprofit causes that make ... Nonprofit Technology Conference (NTC15) in Austin, Texas. The Rev. ... in Austin, was on hand for the presentation; she is ... , Imagine No Malaria was one of five finalists selected ...
(Date:3/4/2015)... 2015 In the Ultimate Fighting Championship, each ... the main event. For UFC 189 , just one ... for the UFC Featherweight Championship. Brazilian champion Jose “Junior” Aldo ... of Ireland, Conor “Notorious” McGregor. UFC 189 will take place ... Las Vegas, NV. , When it comes to the featherweight ...
(Date:3/4/2015)... The Asia-Pacific phthalic anhydride market is estimated to ... at a CAGR of 5.9% during the forecast ... the TOC of Asia-Pacific Phthalic Anhydride Market for ... the help of various tables and figures., ... derivative of phthalic acid, which is either obtained ...
(Date:3/4/2015)... March 04, 2015 Ultraman Florida is ... mile swim, 261.4 mile bike, and 52.4 mile run. ... time of 24:45:45. , "This race was awesome and ... wonderful team and sponsors for supporting me through every ... 2015 had a total of 40 select participants invited ...
(Date:3/4/2015)... March 04, 2015 When people talk about ... top artists spread across numerous genres, the Houston Rodeo ... conversation. Each night during the annual livestock show and rodeo, ... to the other activities being held at the event. The ... of performers that will try and get the festival its ...
Breaking Medicine News(10 mins):Health News:Imagine No Malaria Receives Care2 Innovator Award 2Health News:Imagine No Malaria Receives Care2 Innovator Award 3Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 3Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 2Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 3Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 3
... TITUSVILLE, N.J., Oct. 29 Johnson & ... that it,has submitted a New Drug Application ... for paliperidone palmitate, an investigational,once-monthly atypical antipsychotic ... the prevention of recurrence of the symptoms,of ...
... Va., Oct. 29 The holidays are a,wonderful ... homes are,brightened with the glitter of decorations. In ... overlooked. As decorations go up and,households entertain friends ... to fire and electrocution. This holiday safety program,sponsored ...
... SHENYANG, China, Oct. 29 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc.,(Nasdaq: ... focused on,researching, developing, manufacturing and marketing biopharmaceutical,products, announces ... will,present at the CIBC World Markets 18th Annual ... 2007 at 3:05 PM EST. The presentation ...
... following release is,being issued by the Committee to Reduce ... Durbin,s bill will use Medicare,s purchasing,clout to motivate hospitals ... and a former Lt. Governor of New York State.,"Hospitals ... customer, the,federal government, demands it.", RID OFFERS THE ...
... Vice President Ann Converso, RN, to Serve as President, ... today announced the death of President Cheryl L. Johnson,RN. ... System on,Friday, Oct. 19, with a ruptured brain aneurysm ... family and friends., "Cheryl was a guiding force ...
... Howard A.,McLure, President of Caremark Pharmacy Services, a ... Pharmaceutical Care Management Association,s,(PCMA) Board of Directors, the ... Board Chairman, Mr. McLure was also a keynote ... features health care leaders,discussing the latest industry trends ...
Cached Medicine News:Health News:Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate 2Health News:Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate 3Health News:Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate 4Health News:Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate 5Health News:Video: Holiday Safety Is Important 2Health News:Committee to Reduce Infection Deaths Applauds Senator Durbin's Hospital Infection Legislation, but Suggests Some Crucial Additions in Order to Combat Soaring MRSA Rates 2Health News:UAN Mourns Passing of President Cheryl L. Johnson, RN 2Health News:CVS Caremark's Howard McLure Elected New PCMA Board Chairman 2
... Units,Filter units with hydrophobic PTFE membranes,Millex ... are ideal for the sterilizing filtration ... containers, and for sterilizing or clarifying ... Millex filter units are available with ...
... refrigerator -4C. 5.2 Cubic ... Interior light. Manual push ... drawers. Two shelves. In-door ... Adjustable thermostat. Magnetic gasket. ...
... units with hydrophobic PTFE membranes,Millex filter ... ideal for the sterilizing filtration of ... and for sterilizing or clarifying organic ... filter units are available with different ...
Zero clearance, front breathing, undercounter refrigeration system....
Medicine Products: